Top Markets
Coin of the day
Hexima Limited Hexima Limited

Hexima Limited

HXL
Rangering i aksjer #39776
Hexima Limited is a biotechnology firm focused on the discovery and advancement... Hexima Limited is a biotechnology firm focused on the discovery and advancement of plant-derived proteins and peptides for medical applications in humans. Its primary drug candidate, pezadeftide, a plant defensin, is presently undergoing Phase IIb clinical evaluations in Australia and New Zealand to address fungal toenail infections. The company was established in 1997 and its main operations are situated in Preston, Australia.
Aksjekurs
$0.0084929
Sist synkronisert: 2024-11-12
Markedsverdi
$354.66K
Endring (1 dag)
-0.64%
Endring (1 år)
0.00%
Land
AU
Handel Hexima Limited (HXL)

Kategori

EPS for Hexima Limited (HXL)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Hexima Limited er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Hexima Limited fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter